DEITSCH RIK J 5
5 · NUTRA PHARMA CORP · Filed Jan 14, 2022
Insider Transaction Report
Form 5
DEITSCH RIK J
DirectorPresident, CEO10% Owner
Transactions
- Purchase
Series B Preferred Stock
2021-11-15+9,000,000→ 12,000,000 total - Purchase
Series B Preferred Stock
2021-11-15+3,000,000→ 3,000,000 total
Holdings
- 43,298,859
Common Stock
Footnotes (3)
- [F1]Series B preferred stock have no right of conversion to shares of common stock. Each share of Series B preferred stock is entitled to vote with the Corporation's common stock as a single class on all matters submitted to common stock holders to vote. Each share of Series B Preferred Stock is entitled to one thousand votes per share.
- [F2]3,000,000 shares of Series A Preferred Stock held by Mr. Deitsch were exchanged for an equal number of Series B Preferred Stock of the Company pursuant to a share exchange agreement between Rik Deitsch and the Company.
- [F3]9,000,000 shares of Series B Preferred Stock were issued in satisfaction of corporate debt owed by the Company to Mr. Deitsch pursuant to a resolution adopted by the board of directors of the Company.